| Product Information |
BR-1397_PI_01.pdf
|
| Registration Number |
BR-1397
|
| Generic Name |
Brolucizumab
|
| Brand Name |
Vsiqq
|
| Dosage Strength |
120 mg/mL (27.6 mg/0.23 mL)
|
| Dosage Form |
Solution for Injection (Intravitreal)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
Single use. 0.23 mL in 2 mL Ph. Eur. Type I
colourless glass vial with grey rubber stopper and an aluminum seal with violet flip-off cap + 1 12" 18G filter needle in a soft blister (Box of l's)
|
| Pharmacologic Category |
Antineovascularization Agent
|
| Manufacturer |
Novartis Pharma Stein AG Technical Operations
|
| Country of Origin |
Switzerland
|
| Trader |
|
| Importer |
Novartis Healthcare Philippines, Inc.
|
| Distributor |
|
| Application Type |
Monitored Release (MR)
|
| Issuance Date |
01 April 2022
|
| Expiry Date |
01 April 2027
|